{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:38:08Z","timestamp":1757705888497},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdcjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jdiacomp.2017.02.013","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T22:01:39Z","timestamp":1488837699000},"page":"854-858","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prediction of treatment response in patients with newly diagnosed type 2 diabetes: the Skaraborg diabetes register"],"prefix":"10.1016","volume":"31","author":[{"given":"Miriam","family":"Pikkemaat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olle","family":"Melander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Hjerpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Bengtsson Bostr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives","volume":"8","author":"Chen","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1370\/afm.214","article-title":"Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000","volume":"3","author":"Koopman","year":"2005","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MED.0b013e328350583a","article-title":"The worldwide diabetes epidemic","volume":"19","author":"Lam","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0020","doi-asserted-by":"crossref","first-page":"697240","DOI":"10.1155\/2012\/697240","article-title":"Diabetes and coronary heart disease: a risk factor for the global epidemic","volume":"2012","author":"Chiha","year":"2012","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK prospective diabetes study group","volume":"317","author":"UKPDS","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0030","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1046\/j.1462-8902.2003.0310.x","article-title":"Lipoprotein abnormalities and their consequences for patients with type 2 diabetes","volume":"5","author":"Krentz","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ahj.2014.11.020","article-title":"Copeptin is an independent predictor of diabetic heart disease and death","volume":"169","author":"Enhorning","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/dme.12608","article-title":"C-peptide concentration, mortality and vascular complications in people with type 2 diabetes. The Skaraborg diabetes register","volume":"32","author":"Pikkemaat","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0045","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jdiacomp.2015.07.006","article-title":"Association between copeptin and declining glomerular filtration rate in people with newly diagnosed diabetes. The Skaraborg diabetes register","volume":"29","author":"Pikkemaat","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0055","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/187152711799219271","article-title":"C-peptide and its correlation to parameters of insulin resistance in the metabolic syndrome","volume":"10","author":"Banu","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0060","doi-asserted-by":"crossref","first-page":"e003152","DOI":"10.1161\/JAHA.112.003152","article-title":"Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults","volume":"1","author":"Patel","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0065","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/dc12-1211","article-title":"C-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC study","volume":"36","author":"Marx","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0070","first-page":"1113","article-title":"Relationship between C peptide and chronic complications in type-2 diabetes mellitus","volume":"97","author":"Sari","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0075","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.lpm.2009.02.023","article-title":"C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome","volume":"38","author":"Mavrakanas","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0080","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ijo.2012.88","article-title":"Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmo diet and cancer study cardiovascular cohort","volume":"37","author":"Enhorning","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0085","doi-asserted-by":"crossref","first-page":"E1065","DOI":"10.1210\/jc.2010-2981","article-title":"Plasma copeptin, a unifying factor behind the metabolic syndrome","volume":"96","author":"Enhorning","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/heartjnl-2015-308183","article-title":"Copeptin predicts coronary artery disease cardiovascular and total mortality","volume":"102","author":"Tasevska","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2337\/diacare.27.1.17","article-title":"Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report","volume":"27","author":"Koro","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0100","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1464-5491.2006.01972.x","article-title":"Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old","volume":"23","author":"Berger","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0105","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/diacare.22.5.773","article-title":"Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg diabetes registry","volume":"22","author":"Berger","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00365513.2011.634023","article-title":"Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine","volume":"72","author":"Grubb","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/jc.2008-1426","article-title":"Copeptin in the differential diagnosis of hyponatremia","volume":"94","author":"Fenske","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0125","first-page":"3619","article-title":"Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus","volume":"82","author":"Targher","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1464-5491.2000.00294.x","article-title":"Associations between smoking and beta-cell function in a non-hypertensive and non-diabetic population. Skaraborg hypertension and diabetes project","volume":"17","author":"Ostgren","year":"2000","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/1753-0407.12314","article-title":"Associations of smoking and alcohol consumption with impaired beta-cell function in Chinese men","volume":"8","author":"Xu","year":"2016","journal-title":"J Diabetes"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1365-2362.1997.1330680.x","article-title":"Smoking cessation improves insulin sensitivity in healthy middle-aged men","volume":"27","author":"Eliasson","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0145","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.2337\/dc07-0360","article-title":"Long-term predictors of insulin resistance: role of lifestyle and metabolic factors in middle-aged men","volume":"30","author":"Riserus","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/oby.2007.72","article-title":"Physical inactivity and obesity: a vicious circle","volume":"16","author":"Pietilainen","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.jdiacomp.2017.02.013_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bjsm.33.3.161","article-title":"Diabetes and exercise","volume":"33","author":"Peirce","year":"1999","journal-title":"Br J Sports Med"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872717300557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872717300557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T20:52:36Z","timestamp":1536007956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872717300557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1056872717300557"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.02.013","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of treatment response in patients with newly diagnosed type 2 diabetes: the Skaraborg diabetes register","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}